4//SEC Filing
Mobasher Mehrdad 4
Accession 0000899243-19-002190
CIK 0001626971other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:07 PM ET
Size
5.7 KB
Accession
0000899243-19-002190
Insider Transaction Report
Form 4
Mobasher Mehrdad
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-01-28+210,000→ 210,000 totalExercise: $3.88Exp: 2029-01-28→ Common Stock (210,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to twenty-five percent (25%) of the shares subject to the option on January 28, 2020, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeother
Related Parties
1- filerCIK 0001765484
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:07 PM ET
- Size
- 5.7 KB